Modeling the impact of using trastuzumab deruxtecan in patients with breast cancer on reducing cancer mortality in Russia

Background. Reducing malignant mortality to 185 cases per 100,000 by 2030 is one of goals of the state program “Healthcare development” in Russia.Aim. To assess potential impact of using trastuzumab deruxtecan in patients with breast cancer on reducing cancer mortality.Materials and methods. Three i...

Full description

Saved in:
Bibliographic Details
Main Authors: N. A. Avxentyev, Yu. V. Makarova, A. S. Makarov
Format: Article
Language:Russian
Published: ABV-press 2024-07-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1235
Tags: Add Tag
No Tags, Be the first to tag this record!